Company profile

Oils4Cure

Privately held: no public share price (Spanish biotech developing full-spectrum medicinal cannabis extracts (YCJ-01) for tuberous-sclerosis-associated refractory epilepsy. Small private company, no listing found. Sources: https://clinicaltrials.gov/study/NCT07403266 ; https://oils4cure.com/home/ Entity resolved by asset-pipeline-v2.)

Assets

(1 total)

1Total Assets

0Approved

1Phase 3 / Filed

0Phase 1–2 / Early

1Diseases

Showing 1 of 1 assets

		Target & Modality
YCJ-01	Phase 3	—Botanical	Epilepsy

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.